HTHaydn Till

Haydn Till

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Haydn Till has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Pilot Randomised Controlled Trial of Sublingual Melatonin for Sleep Onset Insomnia in Children With Foetal Alcohol Spectrum Disorder ( FASD )

    by Ned Chandler‐Mather, Doug Shelton, Caroline Donovan, Haydn Till, Bronwyn M. Theroux, Sharon Dawe

    Aim: Children with foetal alcohol spectrum disorder (FASD) present with significant sleep disturbance. This pilot trial aimed to examine the feasibility of conducting a larger randomised controlled trial (RCT) in this population and the potential effectiveness of melatonin to treat onset insomnia. Methods: Children with sleep onset delay and a designation of ‘at risk’ of FASD or a diagnosis of FASD were recruited to a 10‐week, double‐blind, placebo‐controlled, crossover study of melatonin. Sleep outcomes were assessed using actigraphy. The child sleep habit questionnaire (CSHQ) and measures of executive functioning and carer stress were completed at baseline and after each treatment phase. Results: Fifty‐nine children were assessed for eligibility, 18 were ineligible as they were taking sleep medication, and eight children entered the trial. Four received melatonin for 3 weeks followed by placebo for 3 weeks (arm A) and four received placebo followed by melatonin (arm B). Processes involving data collection and retention were acceptable. However, significant issues regarding recruitment were found. Quantitative measures were appropriate with significant reductions in sleep onset latency ( n = 6) in the melatonin condition relative to the placebo condition ( p = 0.003), and bedtime resistance ( n = 8) according to the CSHQ ( p = 0.004). No serious adverse events were reported. Conclusions: A randomised crossover design was feasible in this population; however, recruitment should be conducted across multiple sites. Melatonin is potentially effective at reducing sleep onset latency and behaviour difficulties at bedtime in children with or ‘at risk’ of FASD. Trial Registration: Australian New Zealand Clinical Trials Registry (12619001360101).


  • Open Access

    Multidimensional Scaling of the Wechsler Intelligence Scales for Children in a Clinical Sample Assessed for Fetal Alcohol Spectrum Disorder (FASD)

    by Lee Wolff, Haydn Till, Bruce Watt

    Fetal Alcohol Spectrum Disorder (FASD) is a significant public health concern arising from prenatal alcohol exposure. This study examines the clinical utility of Wechsler intelligence tests in assessing cognition in 108 children with confirmed prenatal alcohol exposure. Data were analysed using multidimensional scaling and Guttman’s Structural Model of Intelligence, with a view to assessing the application of the Wechsler Intelligence Scale for Children 4th Edition (WISC-IV) and 5th Edition (WISC-V) in characterising cognitive ability for this clinical population. WISC-IV and WISC-V subtests exhibited distinct clustering patterns within the sample compared to normative populations. Subtests appeared to cluster based on response modality, aligning with Guttman’s Structural Model of Intelligence. The findings demonstrate an alternative interpretation approach for intelligence tests in children with prenatal alcohol exposure, which may complement existing FASD diagnostic frameworks. The clustering patterns underscore the importance of considering response modality in understanding cognitive abilities.

  • Open Access

    Lived experiences of the diagnostic assessment process for fetal alcohol spectrum disorder: A systematic review of qualitative evidence

    by Nicole Hayes, Kerryn Bagley, Nicole Hewlett, Elizabeth J. Elliott, Carmela F. Pestell, Matthew J. Gullo, Zachary Munn, Philippa Middleton, Prue Walker, Haydn Till, et al.

    Early assessment and diagnosis of FASD are crucial in providing therapeutic interventions that aim to enhance meaningful participation and quality of life for individuals and their families, while reducing psychosocial difficulties that may arise during adolescence and adulthood. Individuals with lived experience of FASD have expertise based on their own lives and family needs. Their insights into the assessment and diagnostic process are valuable for improving service delivery and informing the provision of meaningful, person‐ and family‐centered care. To date, reviews have focused broadly on the experiences of living with FASD. The aim of this systematic review is to synthesize qualitative evidence on the lived experiences of the diagnostic assessment process for FASD. Six electronic databases, including PubMed, the Cochrane Library, CINAH, EMBASE, PsycINFO, and Web of Science Core Collection were searched from inception until February 2021, and updated in December 2022. A manual search of reference lists of included studies identified additional studies for inclusion. The quality of included studies was assessed using the Critical Appraisal Skills Program Checklist for Qualitative Studies. Data from included studies were synthesized using a thematic analysis approach. GRADE‐CERQual was used to assess confidence in the review findings. Ten studies met the selection criteria for inclusion in the review. Thematic analysis identified 10 first‐level themes relating to four over‐arching topics: (1) pre‐assessment concerns and challenges, (2) the diagnostic assessment process, (3) receipt of the diagnosis, and (4) post‐assessment adaptations and needs. GRADE‐CERQual confidence ratings for each of the review themes were moderate to high. The findings from this review have implications for referral pathways, client‐centered assessment processes, and post‐diagnostic recommendations and support.